Journal article · 2015 · Open access

From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients

H‐G Eichler, L G Baird, Richard Barker, Brigitte Bloechl‐Daum, Finn Børlum Kristensen, Jeffrey S. Brown, Rachel Chua, Susanna Del Signore, Ute Dugan, Jeffrey A. Ferguson, S Garner, Wim Goettsch and 29 more

Clinical Pharmacology & Therapeutics, 97(3), 234–246 · Published 4 February 2015 · DOI 10.1002/cpt.59

Open PDFView at the publisherCite this paper

In brief

“From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients” is a 2015 journal article by H‐G Eichler and 40 co-authors, published in Clinical Pharmacology & Therapeutics. OpenAlex counts 229 citations as of 19 November 2026. It is open access under a CC BY licence: the full text is free to read at Clinical Pharmacology & Therapeutics.

Citations
229
Most cited in
2017 (37)
Field-weighted impact
61.59
References
42
Authors
41

Abstract

The concept of adaptive licensing (AL) has met with considerable interest. Yet some remain skeptical about its feasibility. Others argue that the focus and name of AL should be broadened. Against this background of ongoing debate, we examine the environmental changes that will likely make adaptive pathways the preferred approach in the future. The key drivers include: growing patient demand for timely access to promising therapies, emerging science leading to fragmentation of treatment populations, rising payer influence on product accessibility, and pressure on pharma/investors to ensure sustainability of drug development. We also discuss a number of environmental changes that will enable an adaptive paradigm. A life-span approach to bringing innovation to patients is expected to help address the perceived access vs. evidence trade-off, help de-risk drug development, and lead to better outcomes for patients.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Eichler, H., Baird, L. G., Barker, R., Bloechl‐Daum, B., Kristensen, F. B., Brown, J. S., Chua, R., Del Signore, S., Dugan, U., Ferguson, J. A., Garner, S., Goettsch, W., Haigh, J. R., Honig, P. K., Hoos, A., Huckle, P., Kondo, T., Le Cam, Y., Leufkens, H. G. M., . . . Hirsch, G. (2015). From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients. Clinical Pharmacology & Therapeutics, 97(3), 234–246. https://doi.org/10.1002/cpt.59

MLA 9

Eichler, H‐G, et al. “From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients.” Clinical Pharmacology & Therapeutics, vol. 97, no. 3, 2015, pp. 234–246. https://doi.org/10.1002/cpt.59.

Chicago

Eichler, H‐G, L G Baird, Richard Barker, Brigitte Bloechl‐Daum, Finn Børlum Kristensen, Jeffrey S. Brown, Rachel Chua, et al. 2015. “From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients.” Clinical Pharmacology & Therapeutics 97 (3): 234–246. https://doi.org/10.1002/cpt.59.

Harvard

Eichler, H. et al. (2015) ‘From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients’, Clinical Pharmacology & Therapeutics, 97(3), pp. 234–246. doi:10.1002/cpt.59.

IEEE

H. Eichler et al., “From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients,” Clinical Pharmacology & Therapeutics, vol. 97, no. 3, pp. 234–246, 2015, doi: 10.1002/cpt.59.

BibTeX

@article{eichler2015from,
  title     = {{From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients}},
  author    = {Eichler, H‐G and Baird, L G and Barker, Richard and Bloechl‐Daum, Brigitte and Kristensen, Finn Børlum and Brown, Jeffrey S. and Chua, Rachel and Del Signore, Susanna and Dugan, Ute and Ferguson, Jeffrey A. and Garner, S and Goettsch, Wim and Haigh, Jeremy R.M. and Honig, Peter K. and Hoos, Anton and Huckle, P and Kondo, T and Le Cam, Yann and Leufkens, Hubert G. M. and Lim, Robyn R. and Longson, Carole M. and Lumpkin, Murray and Maraganore, John M. and O'Rourke, Brian P and Oye, Kenneth A. and Pezalla, Edmund J. and Pignatti, Francesco and Raine, June M. and Rasi, Guido and Salmonson, Tomas and others},
  journal   = {Clinical Pharmacology \& Therapeutics},
  year      = {2015},
  volume    = {97},
  number    = {3},
  pages     = {234--246},
  doi       = {10.1002/cpt.59},
  url       = {https://doi.org/10.1002/cpt.59}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20173737
20181818
20192323
20201212
20211717
20221212
202355
20241010
20251212
20261717

Its field-weighted citation impact is 61.59: it has been cited 61.59 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy

  • adaptive pathways
  • drug development
  • access to new therapies

Work with this paper

Most-cited papers in Economics, Econometrics and Finance

All highly cited Economics, Econometrics and Finance papers

Questions about this paper

How do I cite this paper in APA style?

Eichler, H., Baird, L. G., Barker, R., Bloechl‐Daum, B., Kristensen, F. B., Brown, J. S., Chua, R., Del Signore, S., Dugan, U., Ferguson, J. A., Garner, S., Goettsch, W., Haigh, J. R., Honig, P. K., Hoos, A., Huckle, P., Kondo, T., Le Cam, Y., Leufkens, H. G. M., . . . Hirsch, G. (2015). From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients. Clinical Pharmacology & Therapeutics, 97(3), 234–246. https://doi.org/10.1002/cpt.59

How many times has this paper been cited?

229 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Clinical Pharmacology & Therapeutics: sign in and open the PDF from this page.

Who wrote this paper?

H‐G Eichler, L G Baird, Richard Barker, Brigitte Bloechl‐Daum, Finn Børlum Kristensen, Jeffrey S. Brown, Rachel Chua, Susanna Del Signore, Ute Dugan, Jeffrey A. Ferguson, S Garner, Wim Goettsch and 29 more.

What is the DOI of this paper?

10.1002/cpt.59, permanently at https://doi.org/10.1002/cpt.59. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.